Skip navigation
Title: 

"He Lied to the People, Saying 'I Am Nebuchadnezzar'": Issues in Authority Control for Rebels, Usurpers, Eccentric Nobility, and Dissenting Royalty

Authors: Mckee, Gabriel
Keywords: Authority files (Information retrieval);Pretenders to the throne;Insurgency
Issue Date: Apr-2022
Publisher: Library Resources & Technical Services
Citation: Gabriel Mckee, “‘He Lied to the People, Saying “I Am Nebuchadnezzar”’: Issues in Authority Control for Rebels, Usurpers, Eccentric Nobility, and Dissenting Royalty,” Library Resources & Technical Services 66, no. 2 (April 2022): 94–107, https://doi.org/10.5860/lrts.66n2.94.
Abstract: Current cataloging guidelines for creating name authority records (NARs) for royalty and nobility assume that an individual’s claim to a royal title is clear and unambiguous. In the case of historical rebels, usurpers, and eccentrics who claim royal titles for themselves, however, the guidelines are not so clear. When we attempt to describe people and places from a disputed past, we actively enter into their struggles for power, but descriptive cataloging standards such as Resource Description and Access (RDA) do not address the question of the legitimacy of a claimed title. Fortunately, recent scholarship on self-determination in NARs for living creators and subject terminology for contested political jurisdictions can help to develop more ethical practices for historical names of ambiguous legitimacy. This paper uses Nidintu-Bēl/Nebuchadnezzar III, a rebel against the Achaemenid emperor Darius I named in the Behistun inscription (6th century BCE), as a case study to establish best practices for the identity management of historical representatives of dissenting royalty.
URI: http://hdl.handle.net/2451/63883
ISSN: 2159-9610
Rights: Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)
Appears in Collections:Gabriel McKee's Collection

Files in This Item:
File Description SizeFormat 
McKee - 2022 - He Lied to the People, Saying 'I Am Nebuchadnezza.pdfHe Lied to the People339.54 kBAdobe PDFView/Open


Items in FDA are protected by copyright, with all rights reserved, unless otherwise indicated.